Inventurus Knowledge Solutions IPO GMP Today, Date, Price, Subscription Status 

Inventurus Knowledge Solutions IPO Overview

Inventurus Knowledge Solutions IPO is a book built issue of Rs 2,497.92 crores. The issue is entirely an offer for sale of 1.88 crore shares.

Inventurus Knowledge Solutions IPO bidding opened for subscription on December 12, 2024 and will close on December 16, 2024. The allotment for the Inventurus Knowledge Solutions IPO is expected to be finalized on Tuesday, December 17, 2024. Inventurus Knowledge Solutions IPO will list on BSE, NSE with tentative listing date fixed as Thursday, December 19, 2024.

Inventurus Knowledge Solutions IPO price band is set at ₹1265 to ₹1329 per share. The minimum lot size for an application is 11 Shares. The minimum amount of investment required by retail investors is ₹14,619. The minimum lot size investment for sNII is 14 lots (154 shares), amounting to ₹204,666, and for bNII, it is 69 lots (759 shares), amounting to ₹1,008,711.

ICICI Securities Limited, Jefferies India Private Limited, Jm Financial Limited, J.P. Morgan India Private Limited and Nomura Financial Advisory And Securities (India) Pvt Ltd are the book running  lead manager of the Inventurus Knowledge Solutions IPO, while Link Intime India Private Ltd is the registrar for the issue.

Refer to Inventurus Knowledge Solutions IPO RHP for detailed information.

Inventurus Knowledge Solutions IPO Important dates

Inventurus Knowledge Solutions IPO opens on December 12, 2024, and closes on December 16, 2024.

IPO Open Date	Thursday, December 12, 2024
IPO Close Date	Monday, December 16, 2024
Basis of Allotment	Tuesday, December 17, 2024
Initiation of Refunds	Wednesday, December 18, 2024
Credit of Shares to Demat	Wednesday, December 18, 2024
Listing Date	Thursday, December 19, 2024
Cut-off time for UPI mandate confirmation	5 PM on December 16, 2024

Inventurus Knowledge Solutions IPO Financial Performance

Inventurus Knowledge Solutions Limited’s revenue increased by 75.25% and profit after tax (PAT) rose by 21.38% between the financial year ending with March 31, 2024 and March 31, 2023.

Inventurus Knowledge Solutions IPO Key Performance Indicator

The market capitalization of Inventurus Knowledge Solutions IPO is Rs 22802.07 Cr.

KPI as of March 31, 2024.

Inventurus Knowledge Solutions IPO Objectives

Inventurus Knowledge Solutions IPO Lot Size

nvestors can bid for a minimum of 11 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.

Application	Lots	Shares	Amount
Retail (Min)	1	11	₹14,619
Retail (Max)	13	143	₹190,047
S-HNI (Min)	14	154	₹204,666
S-HNI (Max)	68	748	₹994,092
B-HNI (Min)	69	759	₹1,008,711

Inventurus Knowledge Solutions IPO Details

IPO Date	December 12, 2024 to December 16, 2024
Listing Date	[.]
Face Value	₹1 per share
Price Band	₹1265 to ₹1329 per share
Lot Size	11 Shares
Total Issue Size	18,795,510 shares (aggregating up to ₹2,497.92 Cr)
Offer for Sale	18,795,510 shares of ₹1 (aggregating up to ₹2,497.92 Cr)
Issue Type	Book Built Issue IPO
Listing At	BSE, NSE
Share holding pre issue	171,573,159
Share holding post issue	171,573,159

Inventurus Knowledge Solutions IPO Company Overview and Services

Incorporated in 2006, Inventurus Knowledge Solutions Limited (IKS Health) provides services to healthcare enterprises such as handling administrative chores/work. The company helps doctors and other healthcare providers by handling their paperwork and administrative tasks. IKS Health offers services such as clinical support, medical documentation management, virtual medical scribing and more.

The company is a healthcare technology company that helps make it easier and faster for patients to get the care they need while reducing the administrative burden on healthcare providers.

Inventurus Knowledge Solutions Limited offer a platform that enables healthcare enterprises in outpatient and inpatient care.

• Outpatient service facilities, also known as ambulatory care, provide medical care without requiring admission to a hospital or other facility and include observation, consultation, diagnosis, rehabilitation, intervention, and treatment services.
• Inpatient care refers to the provision of medical treatment for patients who have been admitted to a hospital or medical facility, requiring an overnight stay or an extended duration.

As of September 30, 2024, IKS serves over 778 healthcare organizations, including health systems, multi-specialty medical groups, and other outpatient and inpatient providers. Key clients include Mass General Brigham Inc., Texas Health Care PLLC, and The GI Alliance Management.

The company has a team of over 13,528 employees, including 2,612 clinically-trained professionals, and a consultative sales force operating in the US, Canada, and Australia.

Their Competitive Strengths:

• Comprehensive one-stop platform with diversified offerings across the outpatient and inpatient care value chain serving key stakeholders such as patients, physicians, nurses and healthcare organizations.
• Leveraging digital evolution, transformation and automation technologies to create sustained value based on outcomes delivered.
• Strong brand amongst healthcare organizations and physicians.
• Sustainable and scalable business model offering clients flexibility and cost-savings and high-touch 215 engagement through access to project executive sponsors and leadership teams creating cross-selling opportunities.

Inventurus Knowledge Solutions IPO SWOT Analysis

Strengths:

• Market Leadership in Healthcare Operations and Analytics: Inventurus has established a strong presence in the US healthcare market, particularly in revenue cycle management (RCM), telehealth, and clinical data optimization.
• Scalable Business Model: The company’s business model allows for expansion without proportionate increases in costs, leading to enhanced profitability.
• Strong Client Retention: Inventurus boasts high client retention rates, with a significant portion of revenue coming from repeat customers. This indicates strong client satisfaction and reliable revenue streams.
• Proprietary Technology: The company utilizes its own technology to deliver scalable, cost-efficient, and high-impact solutions, giving it a competitive edge.
• High-Margin Operations: Inventurus demonstrates high-margin operations, contributing to its strong financial performance.

Weaknesses:

• Dependence on the US Healthcare Market: A significant portion of Inventurus’s revenue is derived from the US healthcare market, making it susceptible to changes in US healthcare policies and regulations.
• Limited Geographic Diversification: The company’s primary focus on the US market limits its geographic diversification and potential for growth in other markets.
• Competition: Inventurus faces competition from other players in the healthcare analytics and RCM space.
• Dependence on Key Clients: While client retention is high, dependence on a few key clients could pose a risk if these relationships weaken.

Opportunities:

• Growth in the US Healthcare Market: The US healthcare market is expected to continue growing, presenting significant expansion potential for Inventurus.
• Increasing Reliance on Outsourced Services: The trend of healthcare providers increasingly relying on outsourced services creates further opportunities for Inventurus to expand its client base.
• Expansion into New Service Offerings: Inventurus can explore expanding its service offerings within the healthcare domain to further diversify its revenue streams.
• Technological Advancements: Continued advancements in healthcare technology can be leveraged to enhance service offerings and efficiency.

Threats:

• Changes in US Healthcare Regulations: Changes in US healthcare regulations could impact Inventurus’s business model and profitability.
• Competition: The healthcare analytics and RCM market is competitive, and increasing competition could put pressure on pricing and margins.
• Economic Downturns: Economic downturns can impact healthcare spending and potentially affect demand for Inventurus’s services.
• Cybersecurity Threats: As a company handling sensitive healthcare data, Inventurus faces cybersecurity threats that could compromise data security and damage its reputation.

Overall:

Inventurus Knowledge Solutions appears to be a well-positioned player in the healthcare analytics and RCM space, with a strong track record and potential for growth. The IPO provides an opportunity for the company to further capitalize on the growing demand for its services. However, investors should also consider the potential weaknesses and threats, such as dependence on the US market and competition.

Inventurus Knowledge Solutions IPO GMP Details

Inventurus Knowledge Solutions IPO Subscription Status 

Total Application : 674,630 (3.96 times)

Disclaimer: *The total amount is calculated based on the final issue price or the price in the upper price range.

Inventurus Knowledge Solutions IPO Allotment status 

Inventurus Knowledge Solutions IPO Contact Details

Inventurus Knowledge Solutions Limited
Building No. 5 & 6, Unit No. 801,
8th Floor, Mindspace SEZ, Thane Belapur Road,
Airoli, Navi Mumbai, Thane, 400708
Phone: +91 22 3964 3205
Email: company.secretary@ikshealth.com
Website: https://ikshealth.com/

Disclaimer: Investing in Initial Public Offerings (IPOs) involves substantial risk, and financial returns are not guaranteed. The information provided should not be construed as financial or investment advice. Prospective investors are advised to consider their financial situation, investment objectives, and risk tolerance before participating in an IPO. It is recommended to consult with a qualified financial advisor or professional before making any investment decisions. Past performance is not indicative of future results. Investments in IPOs may be subject to market risk, including the potential loss of principal.

What is IPO GMP?

The grey market premium (GMP) reflects the unofficial trading price of an IPO before its listing, offering insights into its potential market performance. A positive GMP indicates that the IPO may yield profits, while a negative GMP suggests a possible discount upon listing. However, it’s essential to recognize that IPO GMP can be highly volatile. Therefore, investors should not make decisions solely based on the GMP but should thoroughly assess all relevant factors before investing.

Want to Raise money for your company through SME IPO? Read More